1.00% 0.0795

Advisorshares Psychedelics Etf (PSIL)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Advisorshares Psychedelics Etf Stock (PSIL) Company Profile

Advisorshares Psychedelics Etf

Prossima data di guadagno

Ultimi documenti SEC

PSIL's Discussions on Twitter

Advisorshares Psychedelics Etf Borsa (PSIL) Ultime notizie

Advisorshares Psychedelics Etf Azioni (PSIL) Dati Finanziari

Non sono disponibili dati finanziari per Advisorshares Psychedelics Etf (PSIL). Controlla altri titoli per ulteriori informazioni.

Advisorshares Psychedelics Etf (PSIL)

Advisorshares Psychedelics Etf Stock (PSIL) Company Profile

Advisorshares Psychedelics Etf Borsa (PSIL) Ultime notizie

(PSIL) Trading Signals - Stock Traders Daily

Reverse split for AdvisorShares Psychedelic ETF starts today - Green Market Report

AdvisorShares Announces Reverse Split of ETF - PR Newswire

PSILAdvisorShares Psychedelics ETF Latest Stock News & Market Updates - StockTitan

Cannabis And Psychedelics Industries: Summer's Over, Where Are We? - Benzinga

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading Down 1% - Defense World

VIXY Jumped 7.3% Last Week - Yahoo Finance

Best Psychedelic ETFs - Benzinga

Time for Healthcare ETFs? - Yahoo Finance

Top and Flop ETFs of the First Half - Zacks Investment Research

How to Invest in the Semiconductor Value Chain with These ETFs - The Globe and Mail

Advisorshares Psychedelics ETF (PSIL-A) QuotePress Release - The Globe and Mail

TD Asset Management: The Future of Quantitative Investing - The Globe and Mail

Best and Worst ETF Zones of Q2 - Zacks Investment Research

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Trading 0.9% Higher - Defense World

Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment - Markets Insider

Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment - Benzinga

Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD TreatmentATAI Life Sciences (NASDAQ - Benzinga

Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment - Benzinga

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Stock Holdings Increased by Spire Wealth Management - Defense World

Investors Warm Up to Psychedelics as FDA Reviews Treatment for PTSD - BNN Bloomberg

ETF Issuer: Bristol Gate Capital Partners Inc. - The Globe and Mail

The Impact of Bitcoin Halving on Investors and ETFs to Explore - The Globe and Mail

A New Horizon: Horizons ETF Management Canada to rebrand as Global X - The Globe and Mail

LSD, Ecstasy Lure Traders Betting on ‘Psychedelic Renaissance’ - Bloomberg

Mental Health Mavericks: 3 Stocks Changing the Game - Yahoo Finance

Viridian Capital finds psychedelic stocks typically trade at 3x book - Green Market Report

Psychedelic Funding & Public Markets in 2023 - Psychedelic Alpha

11 Most Promising Psychedelic Stocks According to Hedge Funds - Yahoo Finance

MAPS PBC submits first-ever NDA for MDMA-assisted PTSD therapy - Proactive Investors UK

New Report Predicts Psychedelic Industry Shakeout - Green Market Report

Will Psychedelics Companies Win The Mental Health Boom? - Finimize

How to Invest in Psychedelics - Investing News Network

'We’re in the shakeout stage': The psychedelics boom in healthcare has lost its buzz as some companies struggle to make payroll - Fortune

Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More - Benzinga

Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More - Benzinga

AdvisorShares' Noah Hamman: "It Could Be a Rough, Rough Year" - Nasdaq

PSIL: When Investing In Psychedelic Firms, ETFs Are The Safer Route (NYSEARCA:PSIL) - Seeking Alpha

Options Listed for the AdvisorShares MSOS 2x Daily ETF (Ticker: MSOX) - PR Newswire

The 7 Most Promising Psychedelic Stocks to Buy in February - InvestorPlace

Psychedelics in the Public Markets: 2022 - Psychedelic Alpha

Worst Performing ETFs of 2022 - etf.com

Math Over Myth: Positive Technical Divergences in the Psychedelic Sector - Psychedelic Spotlight

Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3 - Psychedelic Spotlight

Psychedelic Stocks: ARK Invest and the Reverse Midas Touch - Psychedelic Spotlight

7 Psychedelics Stocks to Buy for a Big Drug Boom - Yahoo Finance

AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2x Daily ETF (Ticker: MSOX) - PR Newswire

The Growth Potential Of Psychedelics Stocks And ETFs - Seeking Alpha

The Four Psychedelics ETFs Capturing Investor Attention - Psychedelic Spotlight

Understanding 3 Risks of Investing in Psychedelic Stocks - Psychedelic Spotlight

Best & Worst Performing ETFs Of 2022 - Yahoo Finance

Advisorshares Psychedelics Etf Azioni (PSIL) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a PSIL